• View Press Releases

    View Press Releases

News & Media

Recent News

View All News

Quick Facts

Year founded 1998

Nasdaq SGEN

Number of Employees 1,225+

Global Headquarters Bothell, WA

European Headquarters Zug, Switzerland

icon-sw.png

Primary Product ADCETRIS® (brentuximab vedotin)

adcetris.png

Disease Focus Areas Hodgkin lymphoma, non-Hodgkin lymphoma, urothelial cancer, breast cancer, cervical cancer

heart.png

ADC Collaborations Multiple ADC technology licensing agreements; co-development collaborations with other oncology industry leaders

Resources

Social Media

 

Media Contacts

For Media Professionals Only

Monique Greer, Vice President Corporate Communications

media@seagen.com